Diagnosing idiopathic learning disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United Kingdom.

Diagnosing idiopathic learning disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United Kingdom.

Array based comparative genomic hybridisation (aCGH) is a powerful technique for detecting clinically relevant genome imbalance and can offer 40 to > 1000 times the resolution of karyotyping. Indeed, idiopathic learning disability (ILD) studies suggest that a genome-wide aCGH approach makes 1...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Wordsworth, S, Buchanan, J, Regan, R, Davison, V, Smith, K, Dyer, S, Campbell, C, Blair, E, Maher, E, Taylor, J, Knight, S
Natura:	Journal article
Lingua:	English
Pubblicazione:	2007

Documenti analoghi

Microarray technology in healthcare: A cost analysis in idiopathic learning disability
di: Wordsworth, S, et al.
Pubblicazione: (2006)

Whole genome microarrays for the detection of cryptic genomic imbalances in idiopathic learning disability
di: Regan, R, et al.
Pubblicazione: (2005)

Idiopathic learning disability and genome imbalance.
di: Knight, S, et al.
Pubblicazione: (2006)

Evaluation of array CGH platforms for clinical diagnostic purposes using idiopathic learning disability as a model condition.
di: Regan, R, et al.
Pubblicazione: (2006)

Screening chromosome ends for learning disability - Small chromosomal rearrangements may be behind idiopathic learning disability
di: Knight, S, et al.
Pubblicazione: (2000)

The complete costs of genome sequencing: a microcosting study in cancer and rare diseases from a single center in the United Kingdom
di: Schwarze, K, et al.
Pubblicazione: (2019)

Using genomic information to guide ibrutinib treatment decisions in chronic lymphocytic leukaemia: a cost-effectiveness analysis
di: Buchanan, J, et al.
Pubblicazione: (2017)

Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature
di: Schwarze, K, et al.
Pubblicazione: (2018)

Are whole exome and whole genome sequencing approaches cost-effective? A systematic review of the literature
di: Schwarze, K, et al.
Pubblicazione: (2018)

MANAGING THE LONG-TERM CARE OF INFLAMMATORY BOWEL DISEASE PATIENTS: THE COST TO EUROPEAN HEALTH CARE PROVIDERS
di: Buchanan, J, et al.
Pubblicazione: (2010)

Accurate costs of blood transfusion: a microcosting of administering blood products in the United Kingdom National Health Service
di: Stokes, E, et al.
Pubblicazione: (2018)

Importance and usage of chromosomal microarray analysis in diagnosing intellectual disability, global developmental delay, and autism; and discovering new loci for these disorders
di: Ahmet Cevdet Ceylan, et al.
Pubblicazione: (2018-09-01)

Is DNA testing for hypertrophic cardiomyopathy cost-effective?
di: Wordsworth, S, et al.
Pubblicazione: (2006)

The experiences of women diagnosed with uterine fibroids in the Kingdom of Eswatini
di: Vuyisile J. Ginindza, et al.
Pubblicazione: (2024-11-01)

Tests of Attention in Newly Diagnosed Idiopathic Epilepsy
di: J Gordon Millichap
Pubblicazione: (2002-04-01)

Microarrays. The bridges in the knowledge of mental retardarion diagnosed in childhood
di: Márquez González Horacio, et al.
Pubblicazione: (2014-07-01)

The costs of bipolar disorder in the United Kingdom
di: Simon, J, et al.
Pubblicazione: (2021)

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.
di: Wordsworth, S, et al.
Pubblicazione: (2010)

DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
di: Wordsworth, S, et al.
Pubblicazione: (2010)

Do health professionals value genomic testing? A discrete choice experiment in inherited cardiovascular disease
di: Buchanan, J, et al.
Pubblicazione: (2019)

Subtelomeric rearrangements and idiopathic mental retardation
di: Regan, R, et al.
Pubblicazione: (1999)

Physical Disability in Old Kingdom Tomb Scenes
di: Heba Mahran, et al.
Pubblicazione: (2016-07-01)

Characteristics of adults newly diagnosed with idiopathic hypersomnia in the United States
di: Ragy Saad, et al.
Pubblicazione: (2023-12-01)

Microarray expression analysis in idiopathic and LRRK2-associated Parkinson's disease
di: Teresa Botta-Orfila, et al.
Pubblicazione: (2012-01-01)

Cost of cardiovascular diseases in the United Kingdom.
di: Luengo-Fernández, R, et al.
Pubblicazione: (2006)

Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: A cost-utility analysis comparing meropenem with piperacillin/tazobactam
di: Edwards, S, et al.
Pubblicazione: (2012)

Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam.
di: Edwards, S, et al.
Pubblicazione: (2012)

Recent Application of DNA Microarray Techniques to Diagnose Infectious Disease
di: Asmare Z, et al.
Pubblicazione: (2023-11-01)

Cohen syndrome diagnosed using microarray comparative genomic hibridization
di: Saldarriaga-Gil, Wilmar, et al.
Pubblicazione: (2017-10-01)

Challenges in Diagnosing Narcolepsy and Idiopathic Hypersomnia
di: Seung-Chul Hong, et al.
Pubblicazione: (2023-03-01)

Chromosomal microarrays testing in children with developmental disabilities and congenital anomalies
di: Guillermo Lay‐Son, et al.
Pubblicazione: (2015-03-01)

Chromosomal microarrays testing in children with developmental disabilities and congenital anomalies
di: Guillermo Lay-Son, et al.
Pubblicazione: (2015-03-01)

Chromosomal microarrays testing in children with developmental disabilities and congenital anomalies
di: Guillermo Lay-Son, et al.
Pubblicazione: (2015-04-01)

DISABILITY IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES
di: Natalia LOGHIN-OPREA, et al.
Pubblicazione: (2019-03-01)

Managing the long term care of inflammatory bowel disease patients: The cost to European health care providers.
di: Buchanan, J, et al.
Pubblicazione: (2011)

Dynamics in diagnoses and pharmacotherapy before and after diagnosing idiopathic pulmonary fibrosis
di: Jesper Rømhild Davidsen, et al.
Pubblicazione: (2020-11-01)

Analysis of Microarray-Identified Genes and MicroRNAs Associated with Idiopathic Pulmonary Fibrosis
di: Lichao Fan, et al.
Pubblicazione: (2017-01-01)

Economic costs of biological invasions in the United Kingdom
di: Ross N. Cuthbert, et al.
Pubblicazione: (2021-07-01)

Characteristics of ankylosing spondylitis patients in the United Kingdom
di: Farrat, C, et al.
Pubblicazione: (2008)

Photoelectromechanical synthesis of low-cost DNA microarrays
di: Chow, Brian, 1978-
Pubblicazione: (2008)